P & T Committee interview: Promoting rational drug use

Area of Science:

• Clinical Pharmacy and Hospital Administration
• Pharmacoeconomics and Drug Policy

Background:

• The Pharmacy and Therapeutics (P&T) Committee at the University of California San Francisco (UCSF) Medical Center plays a crucial role in drug management.
• Its evolution reflects the increasing complexity of specialized medical centers and the need for effective drug oversight.

Purpose of the Study:

• To discuss the evolving role and functions of the UCSF P&T Committee.
• To highlight the committee's function as a liaison between quality assurance and medical staff.
• To examine the decision-making processes for drug formulary management in a specialized healthcare setting.

Main Methods:

• The content is based on an interview with key committee members, Dr. Thomas K. Hunt and Dr. Eric T. Herfindal.
• Discussion focuses on the committee's historical development and current operational dynamics.

Main Results:

• The UCSF P&T Committee serves as a critical interface between quality assurance protocols and the medical staff.
• Formulary decisions must accommodate a diverse patient population, necessitating a broad range of pharmaceutical agents.
• Restriction policies are implemented to combat antimicrobial resistance and prevent drug misuse.

Conclusions:

• The committee justifies the use of expensive, novel agents, including those for AIDS treatment, based on ongoing research and patient needs.
• These decisions, often termed 'million-dollar decisions,' underscore the significant financial and clinical impact of the P&T Committee's work.
• The P&T Committee's role is essential for optimizing medication use, ensuring quality patient care, and managing healthcare costs.